REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,987 | -50.3% | 4,533 | +9.7% | 0.00% | – |
| Q2 2023 | $104,547 | -12.2% | 4,131 | +11.7% | 0.00% | – |
| Q1 2023 | $119,109 | +81.3% | 3,698 | +2.7% | 0.00% | – |
| Q4 2022 | $65,692 | -27.0% | 3,600 | +8.3% | 0.00% | – |
| Q3 2022 | $90,000 | +130.8% | 3,324 | +17.1% | 0.00% | – |
| Q2 2022 | $39,000 | -30.4% | 2,838 | 0.0% | 0.00% | – |
| Q1 2022 | $56,000 | +93.1% | 2,838 | +60.6% | 0.00% | – |
| Q4 2021 | $29,000 | -51.7% | 1,767 | -19.0% | 0.00% | – |
| Q3 2021 | $60,000 | -7.7% | 2,182 | -1.5% | 0.00% | – |
| Q2 2021 | $65,000 | +18.2% | 2,216 | +12.2% | 0.00% | – |
| Q1 2021 | $55,000 | -5.2% | 1,975 | -4.0% | 0.00% | – |
| Q4 2020 | $58,000 | -1.7% | 2,057 | -12.9% | 0.00% | – |
| Q3 2020 | $59,000 | +51.3% | 2,362 | +46.3% | 0.00% | – |
| Q2 2020 | $39,000 | +5.4% | 1,615 | -33.2% | 0.00% | – |
| Q1 2020 | $37,000 | – | 2,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |